Immuron (IMRN) Current Assets (2016 - 2025)
Immuron (IMRN) posted quarterly Current Assets of $99780.0 for Q3 2025, down 32.24% year-on-year from $147263.4 in Q3 2024, and down 98.59% on a QoQ basis from $7.1 million in Q2 2025.
Immuron (IMRN) Current Assets (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Current Assets for 10 consecutive years, with $99780.0 the latest figure, recorded in Q3 2025.
- Quarterly Current Assets fell 32.24% year-over-year to $99780.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $99780.0 (down 32.24% YoY) and the FY2025 annual result came in at $99780.0, down 32.24% from the prior year.
- Current Assets declined to $99780.0 in Q3 2025 per IMRN's latest filing, from $7.1 million in the prior quarter.
- Over the last five years, Current Assets for IMRN reached as high as $20.4 million in Q2 2023 and fell as low as $99780.0 in Q3 2025.
- A 5-year average of $10.6 million and a median of $12.4 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets surged 6565.51% — and 2023, when it tumbled 99.2%.
- Year by year, Current Assets stood at $18.2 million in 2021, then retreated by 8.08% to $16.7 million in 2022, then slumped by 99.2% to $133805.8 in 2023, then soared by 6104.45% to $8.3 million in 2024, then sank by 98.8% to $99780.0 in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $99780.0, $7.1 million, and $8.3 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | 99,780.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 99,780.03 |
| Jun 30, 2025 | 7.07 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 9, 2024 | 147,263.37 |
| Jun 30, 2024 | 10.40 Mn |
| Dec 31, 2023 | 133,805.84 |
| Sep 28, 2023 | 14.41 Mn |
| Aug 30, 2023 | 204,093.37 |
| Jun 30, 2023 | 20.41 Mn |
| Dec 31, 2022 | 16.72 Mn |
| Aug 31, 2022 | 16.72 Mn |
| Jun 30, 2022 | 16.72 Mn |
| Dec 31, 2021 | 18.19 Mn |
| Jun 30, 2021 | 18.19 Mn |
| Dec 31, 2020 | 272,856.21 |
| Sep 1, 2020 | 4.41 Mn |
| Jun 30, 2020 | 3.11 Mn |
| Dec 31, 2019 | 44,090.41 |
| Jun 30, 2019 | 6.68 Mn |
| Dec 31, 2018 | 7.05 Mn |